Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anilkumar Pillai

Showing results (31-40 of 103) with videos related to

Pageof 11
Sort By:
Psychoneuroendocrinology|May 22, 2014
Glucocorticoid regulates TrkB protein levels via c-Cbl dependent ubiquitination: a decrease in c-Cbl mRNA in the prefrontal cortex of suicide subjectsChirayu Pandya, Ammar Kutiyanawalla, Gustavo Turecki, et al.
The International Journal of Neuropsychopharmacology|July 23, 2011
Cysteamine treatment ameliorates alterations in GAD67 expression and spatial memory in heterozygous reeler miceAmmar Kutiyanawalla, Wanwisa Promsote, Alvin Terry, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 6, 2012
Antioxidants as potential therapeutics for neuropsychiatric disordersChirayu D Pandya, Kristy R Howell, Anilkumar Pillai
Schizophrenia Research|January 31, 2006
Differential effects of long-term treatment with typical and atypical antipsychotics on NGF and BDNF levels in rat striatum and hippocampusAnilkumar Pillai, Alvin V Terry, Sahebarao P Mahadik
Current Opinion in Psychiatry|January 21, 2011
Brain-derived neurotrophic factor: findings in schizophreniaPeter F Buckley, Anilkumar Pillai, Kristy R Howell
Current Behavioral Neuroscience Reports|July 1, 2020
Galantamine-Memantine Combination as an Antioxidant Treatment for SchizophreniaMaju Mathew Koola, Samir Kumar Praharaj, Anilkumar Pillai
Molecular Psychiatry|August 1, 2023
Activation of cell-free mtDNA-TLR9 signaling mediates chronic stress-induced social behavior deficitsAshutosh Tripathi, Alona Bartosh, Carl Whitehead, et al.
Molecular Autism|September 16, 2014
Dysregulation of estrogen receptor beta (ERβ), aromatase (CYP19A1), and ER co-activators in the middle frontal gyrus of autism spectrum disorder subjectsAmanda Crider, Roshni Thakkar, Anthony O Ahmed, et al.
Molecular Neuropsychiatry|September 8, 2017
Complement C3 Expression Is Decreased in Autism Spectrum Disorder Subjects and Contributes to Behavioral Deficits in RodentsKiley Fagan, Amanda Crider, Anthony O Ahmed, et al.
Translational Psychiatry|February 2, 2022
C1q deletion exacerbates stress-induced learned helplessness behavior and induces neuroinflammation in miceAmit Kumar Madeshiya, Carl Whitehead, Ashutosh Tripathi, et al.
Pageof 11

Showing results (31-40 of 103) with videos related to

Sort By:
Pageof 11
Psychoneuroendocrinology|May 22, 2014
Glucocorticoid regulates TrkB protein levels via c-Cbl dependent ubiquitination: a decrease in c-Cbl mRNA in the prefrontal cortex of suicide subjectsChirayu Pandya, Ammar Kutiyanawalla, Gustavo Turecki, et al.
The International Journal of Neuropsychopharmacology|July 23, 2011
Cysteamine treatment ameliorates alterations in GAD67 expression and spatial memory in heterozygous reeler miceAmmar Kutiyanawalla, Wanwisa Promsote, Alvin Terry, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 6, 2012
Antioxidants as potential therapeutics for neuropsychiatric disordersChirayu D Pandya, Kristy R Howell, Anilkumar Pillai
Schizophrenia Research|January 31, 2006
Differential effects of long-term treatment with typical and atypical antipsychotics on NGF and BDNF levels in rat striatum and hippocampusAnilkumar Pillai, Alvin V Terry, Sahebarao P Mahadik
Current Opinion in Psychiatry|January 21, 2011
Brain-derived neurotrophic factor: findings in schizophreniaPeter F Buckley, Anilkumar Pillai, Kristy R Howell
Current Behavioral Neuroscience Reports|July 1, 2020
Galantamine-Memantine Combination as an Antioxidant Treatment for SchizophreniaMaju Mathew Koola, Samir Kumar Praharaj, Anilkumar Pillai
Molecular Psychiatry|August 1, 2023
Activation of cell-free mtDNA-TLR9 signaling mediates chronic stress-induced social behavior deficitsAshutosh Tripathi, Alona Bartosh, Carl Whitehead, et al.
Molecular Autism|September 16, 2014
Dysregulation of estrogen receptor beta (ERβ), aromatase (CYP19A1), and ER co-activators in the middle frontal gyrus of autism spectrum disorder subjectsAmanda Crider, Roshni Thakkar, Anthony O Ahmed, et al.
Molecular Neuropsychiatry|September 8, 2017
Complement C3 Expression Is Decreased in Autism Spectrum Disorder Subjects and Contributes to Behavioral Deficits in RodentsKiley Fagan, Amanda Crider, Anthony O Ahmed, et al.
Translational Psychiatry|February 2, 2022
C1q deletion exacerbates stress-induced learned helplessness behavior and induces neuroinflammation in miceAmit Kumar Madeshiya, Carl Whitehead, Ashutosh Tripathi, et al.
Pageof 11